IPAMORELIN 10 MG

Ipamorelin is a synthetic pentapeptide research compound studied in laboratory settings as a selective growth hormone secretagogue (GHS). Designed to interact with the ghrelin/GHS receptor, Ipamorelin is examined for its role in growth hormone and endocrine signaling research models. Each vial from Central Peptides contains 10 mg of high-purity Ipamorelin, third-party verified and supplied with a batch-specific Certificate of Analysis (COA) for research use only. As one of the most studied growth hormone secretagogues, Ipamorelin remains a frequently requested compound among Canadian laboratories.

Ipamorelin Research Applications

Ipamorelin is a pentapeptide — a chain of five amino acids — with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2. First described in the mid-1990s and originally developed by Novo Nordisk, it belongs to the class of compounds known as growth hormone secretagogues. Its structure is notable for containing two non-standard amino acids: aminoisobutyric acid (Aib) at the N-terminus and D-2-naphthylalanine (D-2-Nal) in the third position. These modifications distinguish it from naturally occurring peptides and contribute to its stability.

In controlled laboratory environments, researchers study Ipamorelin for its selective agonist activity at the ghrelin/growth hormone secretagogue receptor (GHS-R1a). Research has noted its selectivity for growth hormone release in animal models, with reported minimal impact on other pituitary hormones such as prolactin, FSH, LH, and TSH, making it a useful tool for studying GH-specific pathways.

Common research areas where Ipamorelin is examined include:

• Growth hormone secretagogue receptor (GHS-R1a) binding research
• Ghrelin receptor signaling pathway models
• Endocrine regulation and growth hormone release research
• Metabolic and body-composition research models

Purity and Quality Verification

Every batch of Ipamorelin sold by Central Peptides is manufactured under controlled synthesis and purification processes to ensure stability, consistency, and structural integrity for scientific research applications. Our compounds are independently tested and verified at 99% purity through High-Performance Liquid Chromatography (HPLC) and mass spectrometry.

Each order includes access to a batch-specific Certificate of Analysis, allowing researchers to verify identity, purity percentage, and testing details before use. This batch-level traceability is part of our commitment to transparency and quality control across our full research catalog. Researchers who require documented purity standards for their work can review the COA before and after purchase, ensuring every vial meets the same verified specification.

Product Specifications

• Compound: Ipamorelin (NNC 26-0161)
• Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2 (pentapeptide)
• Quantity: 10 mg per vial
• Purity: 99% (HPLC verified)
• Physical form: Lyophilized powder
• Lab testing: In-house HPLC and mass spectrometry
• COA: Batch-specific, available for every order
• View COA here: Lab Results | CentralPeptides.ca

Storage and Handling

Ipamorelin is supplied as a lyophilized (freeze-dried) powder for maximum stability during shipping and storage. Lyophilization removes moisture from the compound, which helps preserve its structural integrity over time and allows it to remain stable during transit. For long-term integrity, store the lyophilized compound in a cool, dry environment away from light.

Once reconstituted for research, Ipamorelin is soluble in water and should be kept refrigerated at 2-8°C. To preserve compound integrity, aliquot the reconstituted material to avoid repeated freeze-thaw cycles, and use within an appropriate window to maintain consistency in research results.

Shipping Across Canada

Central Peptides ships Ipamorelin and all research compounds across Canada in discreet, temperature-conscious packaging. Orders are typically processed within 24 hours and delivered within 3 to 5 business days. Free delivery is available on qualifying orders over the threshold listed at checkout.

Important Notice

• This product is intended for laboratory research and scientific purposes only.
• It is not approved by Health Canada, the FDA, or any other regulatory authority for human or veterinary use.
• This product is not intended to diagnose, treat, cure, or prevent any disease.
• By purchasing this product, customers acknowledge that it is strictly for research use only.

Buyers are responsible for conducting their own research and understanding the characteristics and intended use of this product prior to purchase.

For additional reference data on this compound, see PubChem: PubChem